← Open Payments lookup

NDUBUISI ODIMEGWU: Open Payments

NPI 1043702467 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$606 in 25 payments from 7 companies in 2025. Trend: 2023 $364 · 2024 $196 · 2025 $606

Food & beverage: $606
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.8$193
Janssen Pharmaceuticals, Inc5$159
Otsuka America Pharmaceutical, Inc.3$75
E.R. Squibb & Sons, L.L.C.3$66
Alkermes, Inc.2$49
AstraZeneca Pharmaceuticals LP3$45
Luye Pharma (USA) Ltd.1$19

Products named: UZEDY, INVEGA SUSTENNA, COBENFY, ARISTADA, REXULTI, AUSTEDO XR, AIRSUPRA, ABILIFY MAINTENA.

Industry payments across TX — which companies pay providers there.